Skip to content

The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity and Preference - Pilot

The Effect of Artificial Sweeteners (AFS) on Sweetness Sensitivity and Preference - Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02335008
Acronym
AFS_pilot
Enrollment
30
Registered
2015-01-09
Start date
2014-09-30
Completion date
2015-07-31
Last updated
2015-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impairment of Oral Perception

Brief summary

The goal of this study is to test the hypothesis that repeated consumption of artificial sweetener reduces sweet taste intensity.

Detailed description

Significant controversy surrounds the possibility that consumption of artificial sweeteners (AFS) leads to weight gain. Some studies have found correlations between AFS use and weight gain and/or diabetes \[1-4\] while others have indicated that AFSs may aid in weight loss \[5\] or have no effects on body mass index (BMI) \[6\]. In rats, exposure to AFS leads to reduced chow intake following a sweet preload \[7, 8\], higher body weight \[9, 10\] and increased glucose responses and decreased GLP1 release following an oral glucose tolerance test \[11\] compared to exposure to caloric sweeteners. Given that the five FDA approved AFSs are found in thousands of foods \[12\] this marks a clear and significant gap in knowledge. Our preliminary data demonstrate a 3-fold decrease in sweet taste sensitivity following consumption of a beverage sweetened with two packets of Splenda for just 10 days. These data provide strong evidence that repeated exposure to sucralose reduces perception of sweet taste intensity, most likely by down-regulation of the sweet taste receptor. Therefore, it is imperative that we gain a greater understanding of the consequences of AFS use, since alterations in sweet taste perception that occur in response to AFS exposure may promote weight gain.

Interventions

DIETARY_SUPPLEMENTSucralose

2 packets per 12 fl oz

DIETARY_SUPPLEMENTSucrose

equisweet to sucralose

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Fluent in English

Exclusion criteria

* History of oral nerve damage, * presence of known taste or smell disorder, * food allergies or sensitivities (for example nuts, lactose, artificial sweeteners), * history of CNS disease, * diabetes, * history of DSM-IV major psychiatric disorder, including alcohol and substance abuse, chronic use of medication that may affect taste, * conditions that may interfere with gustatory or olfactory perception (colds, seasonal allergies, recent smoking history), * aberrant stimulus ratings, * contra-indication for fMRI, * uncomfortable swallowing in supine position.

Design outcomes

Primary

MeasureTime frameDescription
Ratings of taste sensitivityup to one week after interventiongeneral labeled magnitude scale ratings of taste intensity

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026